NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...
Around $6 million is headed to organizations all across the Sunflower State to help community members fight substance abuse.
After 20 years of hemming, hawing, and “evaluating the science,” the FDA is finally muscling its way onto the most coveted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback